ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,852,000 | +139.6% | 307,099 | +43.1% | 0.00% | +100.0% |
| Q3 2019 | $773,000 | +58.4% | 214,608 | +17.8% | 0.00% | 0.0% |
| Q2 2019 | $488,000 | -6.2% | 182,204 | +3.8% | 0.00% | 0.0% |
| Q1 2019 | $520,000 | +86.4% | 175,604 | 0.0% | 0.00% | – |
| Q4 2018 | $279,000 | -56.8% | 175,604 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $646,000 | +25.4% | 175,604 | -3.5% | 0.00% | 0.0% |
| Q2 2018 | $515,000 | -15.2% | 182,004 | +11.2% | 0.00% | 0.0% |
| Q1 2018 | $607,000 | +28.9% | 163,700 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $471,000 | -35.9% | 163,700 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $735,000 | -2.1% | 163,700 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $751,000 | +9.0% | 163,700 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $689,000 | -2.3% | 163,700 | -4.2% | 0.00% | 0.0% |
| Q4 2016 | $705,000 | -49.1% | 170,800 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $1,384,000 | -2.8% | 170,800 | -6.5% | 0.00% | 0.0% |
| Q2 2016 | $1,424,000 | -2.1% | 182,600 | -3.0% | 0.00% | 0.0% |
| Q1 2016 | $1,454,000 | -32.5% | 188,300 | -5.7% | 0.00% | -33.3% |
| Q4 2015 | $2,155,000 | +56.2% | 199,700 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $1,380,000 | -22.0% | 199,700 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $1,769,000 | -42.5% | 199,700 | 0.0% | 0.00% | -25.0% |
| Q1 2015 | $3,079,000 | 0.0% | 199,700 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $3,079,000 | +160.5% | 199,700 | +68.7% | 0.00% | +100.0% |
| Q3 2014 | $1,182,000 | +31.9% | 118,400 | 0.0% | 0.00% | +100.0% |
| Q2 2014 | $896,000 | +148.2% | 118,400 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $361,000 | -10.0% | 118,400 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $401,000 | +8.4% | 118,400 | -3.4% | 0.00% | 0.0% |
| Q3 2013 | $370,000 | -50.7% | 122,600 | +33.7% | 0.00% | -50.0% |
| Q2 2013 | $750,000 | – | 91,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |